In this video interview, Michael Miller, chief operating officer at Quanterix, discusses how the use of biomarkers is ...

The submission is supported by Phase IIIb APEX trial results showing Tremfya reduced symptoms and inhibited structural progression in biologic-naïve patients with active psoriatic arthritis.